JGJudith Giri

Judith Giri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Judith Giri has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Federated, Accessible, Inclusive, and Responsive Virtual Biorepository: Delphi Consensus Study

    by Amy Price, Layla Abdulbaki, Julia Poje, Judith Giri, Zoe Steinberg, Thomas Jaenisch, May Chu

    Background: The reemergence of the Zika virus, the novel coronavirus, and new influenza strains highlighted the urgent need for an organized forum to access specimens to advance research, diagnostics, and vaccine development. During the COVID-19 pandemic, gaps in supply chains, communication, and standards between local (federated) and centralized systems cost time and lives. The FAIR-VBS (Federated, Accessible, Inclusive, and Responsive Virtual Biorepository) was proposed to connect communities with samples, address specimen-sharing challenges, and promote inclusion and equity. Objective: This study aims to enable equitable contribution, sharing, and access to specimens while addressing the complexities involved. The objective is to build stakeholder consensus on prioritized actions, tools, and responsibilities to establish a functional and practical FAIR-VBS. Methods: A Delphi process was conducted online to gather stakeholder input and develop a prioritized action plan for the FAIR-VBS. Respondents were recruited using snowball sampling, and questions were informed by participatory workshops, feedback, outreach efforts, and discussions to identify gaps and best practices. The Delphi process consisted of 2 rounds: an initial ranking informed by stakeholder input and a second round to refine priorities based on the panel feedback. Items were evaluated using a standardized 5-point Likert scale and retained if prioritized by at least 70% of respondents rating an item 4 or higher and no more than 15% rating an item below 2, with descriptive statistics applied. Advisory board discussions supplemented the virtual process to capture nuances, while qualitative data were analyzed using participatory action research methods. Results: The Delphi process evaluated 34 cumulative items across 2 rounds to identify critical gaps and priorities in biorepository systems. In the first round, 22 out of 30 initial items successfully reached consensus. Panelists organically proposed 4 additional items during the first round; upon evaluation in the second round, 2 of these newly proposed items reached consensus, addressing benefit-sharing challenges (11/15, 73%) and the prioritization of whole blood, plasma, and serum samples (40/42, 95%). Culturally, peripheral blood mononuclear cells were supported as a secondary priority (13/18, 72%). In total, 24 items achieved consensus across both rounds, while 10 items overall did not. Respondents overwhelmingly supported the hybrid FAIR-VBS, which combines federated and centralized systems, offering local convenience with virtual oversight (34/41, 83%). Cost recovery for services was supported by all respondents (43/43, 100%), with a preference for a sliding fee scale to subsidize capacity building in low- and middle-income countries (40/42, 95%). Conclusions: Respondents strongly supported the FAIR-VBS to enable equitable access to specimens, services, and benefits. They emphasized the need for clarity on benefit-sharing, regulatory, and ethical frameworks to ensure effective implementation and global inclusivity. A fair and equivalent system to enhance participation and operational continuity is being discussed.

  • Open Access

    An Open Access Collaborative Global Virtual Biorepository System (VBS): A Delphi Consensus

    by Amy Price, Layla Abdulbaki, Julia Poje, Judith Giri, Geoffrey Winstanley, Zoe Steinberg, Thomas Jaenisch, May Chu

    Background: The re-emergence of Zika virus, the novel coronavirus, and new influenza strains highlighted the urgent need for an organized forum to access specimens for advancing research, diagnostics and vaccine development. A Virtual Biorepository System (VBS) was proposed to connect communities and samples, addressing specimen-sharing challenges while promoting inclusion and equity. Aim and Objectives: To enable equitable contribution, sharing, and access to specimens while addressing the complexities involved. The objective is to build stakeholder consensus on prioritized actions, tools, and responsibilities to establish a functional and practical VBS. Methods: A Delphi process was conducted online to gather stakeholder input and develop a prioritized action plan for the VBS. Respondents were recruited using snowball sampling, and questions were informed by participatory workshops, feedback, outreach efforts, and discussions to identify gaps and best practices. The Delphi process consisted of two rounds: an initial ranking informed by stakeholder inputs and a second round of refining priorities based on panel feedback. Consensus threshold was defined as ≥70% of responses rating an item ≥4 and excluded if an item had ≤15% response or was rated < 2 on a 1–5 Likert scale. Advisory board discussions supplemented the virtual process to capture nuances, while qualitative data were analyzed using participatory action research methods. Findings: The Delphi process identified critical gaps and priorities in biorepository systems. Consensus was reached for 22 out of 30 items. Items 20 of 26 in Round-1, with 2 of 4 additional items in Round-2 where consensus was reached on 2 items addressing benefit-sharing challenges (73%) and prioritizing whole blood, plasma, and serum samples (95%). Respondents overwhelmingly supported a hybrid VBS model combining federated and centralized systems (83%) cost recovery for services (100%) Some respondents suggested an equitable fee structure using a sliding scale to subsidize capacity building in low-and middle-income countries (95%). Conclusions: Respondents strongly supported a VBS to enable equitable access to specimens, services, and benefits. They emphasized the need for clarity on benefit-sharing, regulatory, and ethical frameworks to ensure effective implementation and global inclusivity. A fair and equivalent system to enhance participation and operational continuity is being discussed.


  • Open Access

    Specimen sharing for epidemic preparedness: Building a virtual biorepository system from local governance to global partnerships

    by Judith Giri, Laura Pezzi, Rodrigo Cachay, Rosa Margarita Gèlvez Ramirez, Adriana Tami, Sarah Bethencourt, Anyela Lozano, José Eduardo Gotuzzo Herencia, Julia Poje, Thomas Jaenisch, et al.

    We present a framework for a federated, virtual biorepository system (VBS) with locally collected and managed specimens, as a ‘global public good’ model based on principles of equitable access and benefit sharing. The VBS is intended to facilitate timely access to biological specimens and associated data for outbreak-prone infectious diseases to accelerate the development and evaluation of diagnostics, assess vaccine efficacy, and to support surveillance and research needs. The VBS is aimed to be aligned with the WHO BioHub and other specimen sharing efforts as a force multiplier to meet the needs of strengthening global tools for countering epidemics. The purpose of our initial research is to lay the basis of the collaboration, management and principles of equitable sharing focused on low- and middle-income country partners. Here we report on surveys and interviews undertaken with biorepository-interested parties to better understand needs and barriers for specimen access and share examples from the ZIKAlliance partnership on the governance and operations of locally organized biorepositories.


  • Open Access

    Specimen sharing for epidemic preparedness: building a local-to-global virtual biorepository framework

    by Judith Giri, Laura Pezzi, Rodrigo Cachay, Rosa Margarita Gèlvez Ramirez, Adirana Tami, Sarah Bethencourt, Anylea Lozano, Julia Poje, Thomas Jaenisch, May Chu

    We present a framework for a federated, virtual biorepository system (VBS) with locally collected and maintained specimens, based on a ‘global goods’ model and principles of equitable access and benefit sharing. The VBS is intended to facilitate timely access to biological specimens and associated data for outbreak-prone infectious diseases to accelerate the development and evaluation of diagnostics, assess vaccine efficacy, and to support surveillance and research needs. The VBS is aimed to be aligned with the WHO BioHub and other specimen sharing efforts as a force multiplier to meet the needs of strengthening global tools for countering epidemics. The purpose of our research is to lay the basis of the collaboration, management and principles of equitable sharing focused on low- and middle-income country partners. Here we report on surveys and interviews undertaken with biorepository-interested parties to better understand needs and barriers for specimen access and share examples from the ZIKAlliance partnership on the governance and operations of locally organized biorepositories.